View Cart  

Drugmakers: Keep Information Flow on Off-Label Uses Open, Fact Based

Biopharma companies should be allowed to provide factual, non-misleading information about their products’ uses in an open, scientific dialogue whether uses are off-label or not, drugmakers are telling the FDA.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00